The mathematical models of serum HE4 and CA125 combined application to improve the pelvic tumor differential diagnosis rate
暂无分享,去创建一个
Peng Zhang | Wanli Liu | Ying Chen | Xinyu Wen | Jing Chen | Wen Liu | Yi Xu | Lin Guo | Huijun Li | Aimin Zhang | Yaping Tian | Yanchun Huang | Zhongying Zhang | Chuanxin Wang | Liming Cheng | Qishui Ou | Yuelei Xing | Guixi Zheng | Ziyong Sun | Huiming Ye | Yishan Huo
[1] Luis Otávio Sarian,et al. HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated , 2013, The International journal of biological markers.
[2] K. Partheen,et al. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer. , 2013, Gynecologic oncology.
[3] Karina Dahl Steffensen,et al. The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients , 2012, International Journal of Gynecologic Cancer.
[4] Massimo Candiani,et al. Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome. , 2013, Gynecologic oncology.
[5] R. Ivell,et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. , 1991, Biology of reproduction.